Agree Blommer. I think Nearmap has an excellent proposition although a bit overdone above 70c. I'm out at 72 cents - will probably reinvest if it retraces back to low 60s.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
